Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Possible link between androgens and COVID-19 severity; more research needed.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

New therapies are being developed that target integrin pathways to treat various diseases.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Testosterone may influence COVID-19 severity and outcomes.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Anabolic steroid users may face higher risk of severe COVID-19.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.